COMMUNIQUÉS West-GlobeNewswire

OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower
04/12/2024
Vivo Empowers Clinical Development Teams to Accelerate Decision-making and Analyses in Clinical Trials for Improved Outcomes HOUSTON and BOCA RATON, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- OmniScience and INmune Bio ( [...]
Dror Ortho-Design Posts Updated CEO Investor Presentation
04/12/2024
JERUSALEM, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's [...]
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
04/12/2024
SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will [...]
B&D Nutritional Ingredients Announces New Customer Product Launch—A Nutritional Supplement System Supporting GLP-1 Medication Users
04/12/2024
NUTRILINQ™ is a Physician-Formulated Nutritional System Featuring TriBsyn™ CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- B&D Nutritional Ingredients, Inc., a raw material distributor in the dietary supplement [...]
Promex Industries and QP Technologies Appoint Jeannine Serbanich as Vice President of Finance
04/12/2024
Experienced Financial Executive to Streamline Companies’ Financial Processes, Partnering with Leadership Team to Drive Improved Performance ESCONDIDO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Microelectronics and [...]
Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman
04/12/2024
TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]
Konica Minolta Healthcare and Gleamer Partner to Provide Best-in-Class AI-Powered Solution with Konica Minolta's Portfolio of Advanced X-ray Systems
04/12/2024
WAYNE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a leading provider of medical diagnostic imaging and imaging information technology, and Gleamer, a leading European developer of [...]
Boland Romaine LLP is Happy to Announce the Launch of it’s New Website to Better Serve Ontario’s Residents
04/12/2024
Redefining Advocacy for the Injured and The Unsettling Truth About Settling TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort to provide unparalleled legal support and accessibility, Boland Romaine Personal Injury [...]
BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure
04/12/2024
Next PMDA Consultation after Review of CardiAMP HF Trial Data SUNNYVALE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the [...]
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET
04/12/2024
NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
04/12/2024
Full-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic visits BOCA RATON, Fla, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: [...]
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
04/12/2024
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]
NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
04/12/2024
EDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Teva présente des données positives sur l’efficacité et la sécurité d’emploi d’AJOVY® (frémanézumab) pour la prévention de la migraine épisodique chez les enfants et les adolescents dans le cadre de l’essai clinique de phase III SPACE
04/12/2024
AJOVY ® (frémanézumab) a permis de réduire de manière significative le nombre de jours de migraine mensuels (MMD, de l’anglais « monthly migraine days ») et le nombre de jours de céphalées mensuels (MHD, de l’anglais « [...]
Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
04/12/2024
First positive reimbursement decision worldwide for LYTENAVA™; First launch anticipated in H1 2025 LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the [...]
Adaptive Research Welcomes Western Radiation Oncology to Expand Community Access to Pioneering Cancer Treatment Trials
04/12/2024
SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Adaptive Research and Western Radiation Oncology (WRO) have announced that WRO has joined Adaptive Research’s growing network of community physician practices. This [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
03/12/2024
Company Announcement COPENHAGEN, Denmark; December 3, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 10,355 shares as a consequence of the exercise of employee warrants. The increase is effected [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/12/2024
WAYNE, Pa., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS)(the “Company” or “Aclaris”), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno- [...]
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/12/2024
WALTHAM, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

Pages